A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects

A Phase 1, Randomized, Partial-Blind, Placebo-controlled, Sequential Dose Group, Ascending, Multiple Dose Study of the Safety, Tolerability and Pharmacokinetics, With Food Effect, of CMX157 in Healthy Subjects

This is a phase 1 study to evaluate the safety and tolerability of multiple oral doses of CMX157 at increasing dose levels.

This is a phase 1 study to evaluate the safety and tolerability of multiple oral doses of CMX157 at increasing dose levels, in a fasted state and a fed state.

Inclusion Criteria:

• Age: 18-55.
• Capable of giving written informed consent.
• Capable of completing study requirements.

Exclusion Criteria:

• Positive result for HIV, HBV, or HCV.
• History or medical condition which could impact patient safety.
• Current or past abuse of alcohol or illicit drugs.
• Participation in another clinical trial within the past 30 days.